Macrophage activation marker soluble CD163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|8|1293-1300

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.8, 2015-08, pp. : 1293-1300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 36, Iss. 10, 2016-10 ,pp. : 1549-1557

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral fructose absorption in obese children with non‐alcoholic fatty liver disease

By  

PEDIATRIC OBESITY, Vol. 10, Iss. 3, 2015-06 ,pp. : 188-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

Orthotopic Liver Transplantation in Non-Alcoholic Fatty Liver Disease Patients

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 210-216

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease

By Tapan Serkan   Dogru Teoman   Kara Muammer   Ercin C Nuri   Kilciler Guldem   Genc Halil   Sertoglu Erdim   Acikel Cengizhan   Kilic Selim   Karslioglu Yildirim   Kurt Ismail   Erbil Mehmet K.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 6, 2010-10 ,pp. : 399-403

Informa Healthcare

Access to resources Recommend Favorite